Detailed information for compound 1522456

Basic information

Technical information
  • Name: Unnamed compound
  • MW: 283.327 | Formula: C19H13N3
  • H donors: 0 H acceptors: 3 LogP: 3.67 Rotable bonds: 2
    Rule of 5 violations (Lipinski): 1
  • SMILES: n1ccc(cc1)c1cncnc1c1ccc2c(c1)cccc2
  • InChi: 1S/C19H13N3/c1-2-4-16-11-17(6-5-14(16)3-1)19-18(12-21-13-22-19)15-7-9-20-10-8-15/h1-13H
  • InChiKey: FYTQPCAWJIMNQU-UHFFFAOYSA-N  

Network

Hover on a compound node to display the structore

Synonyms

No synonyms found for this compound

Targets

Known targets for this compound

Species Target name Source Bibliographic reference
Homo sapiens mitogen-activated protein kinase 10 Starlite/ChEMBL References
Homo sapiens mitogen-activated protein kinase 8 Starlite/ChEMBL References

Predicted pathogen targets for this compound

By orthology
Species Potential target Known druggable target/s Ortholog Group
Echinococcus granulosus c-Jun N-terminal kinases Get druggable targets OG5_129677 All targets in OG5_129677
Echinococcus multilocularis c Jun NH2 terminal kinase Get druggable targets OG5_129677 All targets in OG5_129677
Brugia malayi Stress-activated protein kinase jnk-1 Get druggable targets OG5_129677 All targets in OG5_129677
Schistosoma japonicum IPR000164,Histone H3;IPR009072,Histone-fold,domain-containing Get druggable targets OG5_129677 All targets in OG5_129677
Loa Loa (eye worm) CMGC/MAPK/JNK protein kinase Get druggable targets OG5_129677 All targets in OG5_129677
Schistosoma mansoni serine/threonine protein kinase Get druggable targets OG5_129677 All targets in OG5_129677
Schistosoma japonicum ko:K04440 c-Jun N-terminal kinase, putative Get druggable targets OG5_129677 All targets in OG5_129677

By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Loa Loa (eye worm) ryanodine receptor 0.0181 0.2448 0.2448
Schistosoma mansoni inositol 145-trisphosphate receptor 0.0148 0.1788 0.1788
Echinococcus granulosus ryanodine receptor 44f 0.0392 0.6688 0.3434
Echinococcus multilocularis ryanodine receptor 44f 0.0392 0.6688 0.3434
Trypanosoma brucei inositol 1,4,5-trisphosphate receptor 0.0174 0.2321 0.5
Trypanosoma cruzi inositol 1,4,5-trisphosphate receptor, putative 0.0174 0.2321 0.5
Loa Loa (eye worm) hypothetical protein 0.0306 0.4956 0.4956
Leishmania major hypothetical protein, conserved 0.0119 0.1199 0.5
Echinococcus granulosus c-Jun N-terminal kinases 0.0557 1 1
Loa Loa (eye worm) hypothetical protein 0.0092 0.0666 0.0666
Schistosoma mansoni ryanodine receptor related 0.0484 0.8538 0.8538
Schistosoma mansoni hypothetical protein 0.0119 0.1214 0.1214
Brugia malayi Ryanodine Receptor TM 4-6 family protein 0.0484 0.8538 0.792
Loa Loa (eye worm) hypothetical protein 0.0088 0.0589 0.0589
Schistosoma mansoni serine/threonine protein kinase 0.0557 1 1
Loa Loa (eye worm) CMGC/MAPK/JNK protein kinase 0.0557 1 1
Echinococcus multilocularis c Jun NH2 terminal kinase 0.0557 1 1
Loa Loa (eye worm) ryanodine receptor 0.0114 0.111 0.111

Activities

Activity type Activity value Assay description Source Reference
IC50 (binding) = 4.13 uM Inhibition of JNK3 by TR-FRET assay ChEMBL. 21570836
IC50 (binding) = 18.1 uM Inhibition of JNK2 by TR-FRET assay ChEMBL. 21570836
IC50 (binding) > 50 uM Inhibition of JNK1 by TR-FRET assay ChEMBL. 21570836
Stability (ADMET) = 0 % Oxidative metabolic stability in mouse liver microsomes assessed as compound remaining after 30 mins ChEMBL. 21570836

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

1 literature reference was collected for this gene.

If you have references for this compound, please enter them in a user comment (below) or Contact us.